SCHEMBL5145484

SCHEMBL5145484

COC(N)c1cn([C@H]2O[C@@H](CO)C(O)C2O)c(=S)[nH]c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGM P11217 3/20 0.49
P2RY2 P41231 1/20 0.46
SLC28A1 O00337 1/20 0.44
SLC28A2 O43868 1/20 0.44
SLC29A1 Q99808 1/20 0.44
SLC28A3 Q9HAS3 1/20 0.44
TK2 O00142 2/20 0.43
CDK1 P06493 1/20 0.40
LMNA P02545 2/20 0.40
MTOR P42345 2/20 0.40
THRB P10828 1/20 0.40
MDM2 Q00987 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
GMNN O75496 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
NFKB1 P19838 1/20 0.40
DNMT1 P26358 1/20 0.40
THPO P40225 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27965304 1.00 PYGM (0.49) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL21458099 0.88 PYGM (0.52) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL6549359 0.85 PYGM (0.47) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL28344680 0.84 PYGM (0.50) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL27760732 0.83 PYGM (0.51) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL441977 0.82 PYGM (0.48) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL20534354 0.82 PYGM (0.48) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL1932437 0.82 PYGM (0.50) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL29002253 0.82 PYGM (0.46) PYGMP2RY2SLC28A1SLC28A2SLC29A1
SCHEMBL1067013 0.81 PYGM (0.52) PYGMP2RY2SLC28A1SLC28A2SLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118786212-A SARM1 expression reduction for cell therapy 埃门多生物公司 2024-10-15 CN disclosed
CN-118355348-A Hepatitis B Virus (HBV) knockout 埃门多生物公司 2024-07-16 CN disclosed
CN-116157515-A Double allele knockout of SARM1 埃门多生物公司 2023-05-23 CN disclosed
CN-103275980-B Antibody, fusion rotein and composition UNIV RUTGERS (US) 2015-09-09 CN disclosed
EP-2854844-A2 COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST Ophthotech Corporation (US) 2015-04-08 EP disclosed
WO-2013181495-A2 COMPOSITIONS COMPRISING AN ANTI-PDGF APTAMER AND A VEGF ANTAGONIST OPHTHOTECH CORPORATION (US) 2013-12-05 WO disclosed
CN-103275980-A Antibodies, fusion protein and composition UNIV NEW JERSEY MED 2013-09-04 CN disclosed
CN-101511181-B Proteins, nucleic acids encoding the same and related methods of use UNIV NEW JERSEY MED 2013-08-21 CN disclosed
US-20130164748-A1 Detection of nucleic acid amplification APPLIED BIOSYSTEMS LLC (US) 2013-06-27 US disclosed
CN-101511181-A Proteins, nucleic acids encoding the same and related methods of use UNIV MEDICINE AND DENTISTRY (US) 2009-08-19 CN disclosed
US-20070099211-A1 Detection of nucleic acid amplification APPLIED BIOSYSTEMS, LLC 2007-05-03 US disclosed
US-20060121510-A1 Multidomain polynucleotide molecular sensors NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-06-08 US disclosed